Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych CASC / OSCEPsychopharmacology — ECT and neurostimulation

Psych CASC / OSCE · Psychopharmacology — ECT and neurostimulation

Explaining ECT and cognitive risk to a patient and partner (CASC)

CASC-style communication station: shared decision on acute ECT vs rTMS, honest cognitive risk counselling, consent elements, and relapse-prevention framing without stigma or false reassurance.

communication
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 45-year-old with severe melancholic depression and previous near-lethal overdose sits with her partner. She has failed two adequate antidepressant trials. She says 'ECT fries your brain and steals your memories'. The partner asks why not 'just do that magnet treatment instead'.

Station instructions (candidate)

You have 7 minutes. Explain why ECT is being recommended for severe treatment-resistant melancholic depression with high risk, what modern ECT involves (anaesthesia, not a horror scene), cognitive risks honestly, and how rTMS/iTBS differs in urgency and evidence role. Invite questions. Do not guarantee cure. Do not dismiss fears. Do not invent legal section numbers. Offer written information and a follow-up for consent formalities.[1][2][3][5][7]

Marking domains

Empathy and agenda setting; accurate plain-language explanation of indication and modern technique; honest memory risk counselling with mitigation (placement/pulse width); clear comparison with rTMS (outpatient, no anaesthetic, different evidence niche, not equivalent for this severity/urgency); discussion of common side effects and rare serious risks; continuation/relapse-prevention mention; collaborative plan and check-back.[1][2][3][4][5][6]

Model communication map

  1. Open: thank them; ask what they have heard about ECT; acknowledge fear without ridicule.[2]
  2. Why now: severe depression has not responded to two proper medicine trials; symptoms include high suicide risk features; ECT is among the most effective short-term treatments for this severity.[1][2]
  3. What happens: short general anaesthetic, muscle relaxant, brief controlled electrical stimulation that produces a short seizure in the brain while the body is protected; oxygen and monitoring; usually two or three times a week for a course individualised to response.[2][7]
  4. Memory — honest: temporary confusion after sessions; learning can be fuzzy during the course and usually improves; some people notice gaps in personal memories around the treatment period — we take that seriously, choose techniques that reduce that risk where safe (for example right-sided and ultrabrief approaches), and monitor.[3][4]
  5. "Magnet treatment" (rTMS): real option for many people with treatment-resistant depression who are medically stable outpatients; no anaesthetic; good trial evidence including shorter theta-burst sessions. For this current severity and risk profile, ECT is more appropriate acutely; rTMS can be discussed later if the clinical picture fits.[5]
  6. Aftercare: medicines and/or spaced continuation ECT to reduce relapse — finishing the acute course is not the end of the plan.[6]
  7. Close: questions, written info, consent process next steps, partner support, crisis contacts.[7]

Common fails

  • Saying "ECT never affects memory" or "ECT always permanently destroys memory".[3]
  • Describing unmodified historical ECT imagery as current practice.[2]
  • Dismissing rTMS as fake or promising rTMS as identical to ECT for malignant-risk depression.[5]
  • Omitting relapse-prevention after successful treatment.[6]
  • Coercive language without exploring values, or abandoning recommendation when risk is high and capacity is intact but fear is based on myth alone (explore, correct, re-recommend).[7]

References

  1. [1]UK ECT Review Group Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis Lancet, 2003.PMID 12642045
  2. [2]Espinoza RT, Kellner CH Electroconvulsive Therapy N Engl J Med, 2022.PMID 35172057
  3. [3]Sackeim HA, Prudic J, Fuller R, et al. The cognitive effects of electroconvulsive therapy in community settings Neuropsychopharmacology, 2007.PMID 16936712
  4. [4]Sackeim HA, Prudic J, Nobler MS, et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy Brain Stimul, 2008.PMID 19756236
  5. [5]Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D) Lancet, 2018.PMID 29726344
  6. [6]Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: CORE Arch Gen Psychiatry, 2006.PMID 17146008
  7. [7]Weiss A, Hussain S, Ng B, et al. RANZCP professional practice guidelines for the administration of electroconvulsive therapy Aust N Z J Psychiatry, 2019.PMID 30966782